OXiGENE, Inc. (NASDAQ:OXGN)
| CAPS Rating |
|
|---|
OXGN
VS S&P 500 (SPY)
OXGN News and Commentary
- Small Biotechnology Stocks Roar, Profit Now – Blog at The Motley Fool
- Inhibitex Investors: Why Shares Popped 115% – The Motley Fool
- You Should Have Seen These Biotech Failures Coming – The Motley Fool
- Alert: Key Small Cap Stocks Start Waking Up – Blog at The Motley Fool
- Major Pops In Large And Small Cap Stocks – Blog at The Motley Fool
- Stock Market Movers And Key Small Cap Alert – Blog at The Motley Fool
- ASCO Pops and Drops – The Motley Fool
- Big Pharma Tackles Lung Cancer; Biotech Helping, Too – The Motley Fool
- Cancer Data Deluge Ripples Through Biotech Stocks – SmartMoney
How do you think OXGN will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
67
Outperform
23
Underperform
All-Star Players
10
Outperform
9
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
